The Decade of Vaccines (DoV) Collaboration was both a catalyst and a convener – paving the way to extend the full benefits of immunization to all people, regardless of where they live.
As a catalyst, the DoV Collaboration contributed to and enhanced coordination across the international development, health, vaccine and immunization community.
As a convener, the DoV Collaboration brought together diverse stakeholders to develop a Global Vaccine Action Plan (GVAP) to stimulate the discovery, development and delivery of lifesaving vaccines. The plan builds on the success of current work to transform the way vaccines move from formulation, to factory, to families.
Leading health, development, vaccine and immunization experts from around the world supported this initiative through participation in the DoV Collaboration Leadership Council, Steering Committee, Working Groups and consultation process. They donated their time and expertise to the DoV Collaboration, serving in an individual, not institutional capacity. Additional institutional, research, and financial support was provided by the founding partners of the initiative: the World Health Organization, UNICEF, the National Institute of Allergy and Infectious Diseases, and the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation made a specific grant to ISGlobal, PATH and the Sabin Vaccine Institute, the organizations hosting the DoV Collaboration Secretariat.
On 25 May 2012, the World Health Assembly, composed of the 194 Member States of the World Health Organization (WHO), approved the GVAP and its accompanying resolution. The DoV Collaboration was a time-limited consultation process, the success of which depended on the commitment and active engagement of organizations and individuals around the world. As planned, the DoV Collaboration dissolved at the end of 2012 so as not to create additional structures. The work is now being mainstreamed to the primary agencies involved, and the DoV work will continue through 2020.